ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 90 filers reported holding ENZO BIOCHEM INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $7,000 | -96.6% | 2,135 | -96.4% | 0.00% | -100.0% |
| Q1 2021 | $203,000 | -58.1% | 58,920 | -69.4% | 0.00% | -66.7% |
| Q4 2020 | $485,000 | +19.2% | 192,573 | -0.3% | 0.00% | 0.0% |
| Q3 2020 | $407,000 | -5.8% | 193,093 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $432,000 | -7.1% | 193,093 | +4.9% | 0.00% | 0.0% |
| Q1 2020 | $465,000 | -21.8% | 184,076 | -18.6% | 0.00% | 0.0% |
| Q4 2019 | $595,000 | -11.7% | 226,112 | +20.8% | 0.00% | 0.0% |
| Q3 2019 | $674,000 | +16750.0% | 187,103 | +14160.9% | 0.00% | – |
| Q2 2019 | $4,000 | -77.8% | 1,312 | -80.4% | 0.00% | – |
| Q1 2019 | $18,000 | -63.3% | 6,693 | -61.9% | 0.00% | – |
| Q4 2018 | $49,000 | -31.9% | 17,563 | 0.0% | 0.00% | – |
| Q3 2018 | $72,000 | -20.9% | 17,563 | 0.0% | 0.00% | – |
| Q2 2018 | $91,000 | -78.3% | 17,563 | -77.1% | 0.00% | -100.0% |
| Q1 2018 | $420,000 | -89.2% | 76,703 | -83.9% | 0.00% | -86.7% |
| Q4 2017 | $3,891,000 | -30.3% | 477,426 | -10.5% | 0.02% | -31.8% |
| Q3 2017 | $5,582,000 | +6.6% | 533,144 | +12.4% | 0.02% | +4.8% |
| Q2 2017 | $5,236,000 | +136.1% | 474,237 | +79.0% | 0.02% | +133.3% |
| Q1 2017 | $2,218,000 | +37.6% | 264,981 | +14.1% | 0.01% | +28.6% |
| Q4 2016 | $1,612,000 | +2418.8% | 232,302 | +1739.0% | 0.01% | – |
| Q3 2016 | $64,000 | -39.0% | 12,632 | -27.9% | 0.00% | -100.0% |
| Q2 2016 | $105,000 | -27.6% | 17,528 | -45.1% | 0.00% | 0.0% |
| Q1 2016 | $145,000 | +83.5% | 31,911 | +82.1% | 0.00% | – |
| Q4 2015 | $79,000 | +41.1% | 17,528 | 0.0% | 0.00% | – |
| Q3 2015 | $56,000 | +5.7% | 17,528 | 0.0% | 0.00% | – |
| Q2 2015 | $53,000 | -66.0% | 17,528 | -66.9% | 0.00% | -100.0% |
| Q1 2015 | $156,000 | -39.8% | 52,905 | -9.3% | 0.00% | 0.0% |
| Q4 2014 | $259,000 | -30.9% | 58,332 | -19.8% | 0.00% | -50.0% |
| Q3 2014 | $375,000 | -33.6% | 72,764 | -32.4% | 0.00% | -33.3% |
| Q2 2014 | $565,000 | +18.9% | 107,635 | -5.7% | 0.00% | +50.0% |
| Q1 2014 | $475,000 | +550.7% | 114,146 | +223.6% | 0.00% | – |
| Q2 2013 | $73,000 | – | 35,278 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |